Pharmacokinetic-pharmacometabolomic approach in early-phase clinical trials: A way forward for targeted therapy in type 2 diabetes
Pharmacometabolomics in early phase clinical trials demonstrate the metabolic profiles of a subject responding to a drug treatment in a controlled environment, whereas pharmacokinetics measure the drug plasma concentration in human circulation. Application of the personalized peak plasma concentrati...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
MDPI
2022
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/41969/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universiti Malaya |